Jing Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jing Yang has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Chuangchuang Zhou
Affiliation College of Veterinary Medicine, Yunnan Agricultural University, Kunming, Yunnan, China
1 shared publicationChunli Yang
Affiliation College of Veterinary Medicine, Yunnan Agricultural University, Kunming, Yunnan, China
1 shared publication- Ganzhen Deng
Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, People’s Republic of China
1 shared publication - Jinyin Cai
College of Veterinary Medicine, Yunnan Agricultural University, Kunming 650201, Yunnan, China
1 shared publication - Juan J. Loor
Department of Animal Sciences, University of Illinois, Urbana, IL 61801, USA
1 shared publication - Kangfeng Jiang
College of Veterinary Medicine, Yunnan Agricultural University, Kunming, China
1 shared publication
Latest Publications
- Open Access
- 13 March 2026
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 20 (3) , e0014108
Gut microbiota-associated metabolite N-acetyl-D-glucosamine alleviates systemic inflammatory responses induced by acute Toxoplasma gondii infection
Toxoplasma gondii ( T. gondii ) is an opportunistic protozoan parasite capable of infecting nearly all warm-blooded animals, including humans. Infection with T. gondii often triggers potent inflammatory responses that can lead to severe and potentially life-threatening tissue damage. Based on the mechanistic relationship between the gut microbiota and the host immune system, this study explores the metabolic regulatory network orchestrated by the gut microbiota during T. gondii infection. Using intraperitoneal infection models with both a wild-type ME49 strain and an attenuated ME49Δ α-amy strain, we report for the first time a pivotal role for N-acetyl-D-glucosamine (GlcNAc) in modulating parasite-induced inflammation. Integrated analysis of 16S rRNA sequencing and metabolomic profiling revealed that GlcNAc, a gut microbiota-associated metabolite, was significantly enriched in mice infected with the ME49Δ α-amy strain. Exogenous administration of GlcNAc to T. gondii -infected mice resulted in the marked downregulation of key pro-inflammatory cytokines, including TNF-α, IL-1β, IL-6, and IL-12, and a significant upregulation of the anti-inflammatory cytokines IL-10 and TGF-β. Moreover, GlcNAc treatment substantially reduced parasite burden and alleviated infection-associated weight loss. These findings not only elucidate the immunomodulatory function of microbiota-related metabolites in the context of zoonotic parasitic infections but also provide a novel theoretical foundation for the development of microbiota-targeted therapeutic strategies against toxoplasmosis. Collectively, our work offers important insights that may inform public health interventions aimed at controlling and preventing zoonotic parasitic diseases.
- 13 March 2026
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 20 (3) , e0014108
Open AccessGut microbiota-associated metabolite N-acetyl-D-glucosamine alleviates systemic inflammatory responses induced by acute Toxoplasma gondii infection
Toxoplasma gondii ( T. gondii ) is an opportunistic protozoan parasite capable of infecting nearly all warm-blooded animals, including humans. Infection with T. gondii often triggers potent inflammatory responses that can lead to severe and potentially life-threatening tissue damage. Based on the mechanistic relationship between the gut microbiota and the host immune system, this study explores the metabolic regulatory network orchestrated by the gut microbiota during T. gondii infection. Using intraperitoneal infection models with both a wild-type ME49 strain and an attenuated ME49Δ α-amy strain, we report for the first time a pivotal role for N-acetyl-D-glucosamine (GlcNAc) in modulating parasite-induced inflammation. Integrated analysis of 16S rRNA sequencing and metabolomic profiling revealed that GlcNAc, a gut microbiota-associated metabolite, was significantly enriched in mice infected with the ME49Δ α-amy strain. Exogenous administration of GlcNAc to T. gondii -infected mice resulted in the marked downregulation of key pro-inflammatory cytokines, including TNF-α, IL-1β, IL-6, and IL-12, and a significant upregulation of the anti-inflammatory cytokines IL-10 and TGF-β. Moreover, GlcNAc treatment substantially reduced parasite burden and alleviated infection-associated weight loss. These findings not only elucidate the immunomodulatory function of microbiota-related metabolites in the context of zoonotic parasitic infections but also provide a novel theoretical foundation for the development of microbiota-targeted therapeutic strategies against toxoplasmosis. Collectively, our work offers important insights that may inform public health interventions aimed at controlling and preventing zoonotic parasitic diseases.
- 1 January 2024
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 107 (1) , 555-572
Interferon-tau protects bovine endometrial epithelial cells against inflammatory injury by regulating the PI3K/AKT/β-catenin/FoxO1 signaling axis
Endometritis is one of the most common causes of infertility in dairy cows, and is histopathologically characterized by inflammation and damage of endometrial epithelium. Interferon-tau (IFN-τ) is a novel type I interferon secreted by ruminant trophoblast cells with low cytotoxicity even at high doses. Previous studies suggested that IFN-τ plays an important role in inflammation. However, the mechanisms whereby IFN-τ may modulate the inflammatory responses in the bovine endometrium are unknown. In the present study, primary bovine endometrial epithelial cells (BEEC) isolated from fresh and healthy uterine horns were used for in vitro studies. The integrity of BEEC was assessed by immunofluorescence staining for cytokeratin 18 (CK-18, a known epithelial marker). For the experiments, BEEC were stimulated with different concentrations of lipopolysaccharide (LPS; 0-20 µg/mL) for different times (0-24 h). Cell viability and apoptosis were assessed via CCK-8 and flow cytometry. In a preliminary study, we observed that compared with the control group without LPS, 10 µg/mL of LPS stimulation for 24 h induced apoptosis. In a subsequent study, 20 or 40 ng/mL of IFN-τ alleviated LPS-induced apoptosis. Relative to the LPS group, western blotting further revealed that IFN-τ inhibited the protein abundance of TLR4 and phosphorylated (p-) p65 (p-p65) and Bax/Bcl-2 ratio, suggesting that IFN-τ can protect BEEC against inflammatory injury. Furthermore, the protein abundance of p-phosphoinositide 3-kinase (p-PI3K), p-protein kinase B (p-AKT), p-glycogen synthase kinase-3β (p-GSK3β), β-catenin, and p-forkhead box O1 (p-FoxO1) was lower in the LPS group, whereas IFN-τ upregulated their abundance. The use of LY294002, a specific inhibitor of PI3K/AKT, attenuated the upregulation of p-PI3K, p-AKT p-GSK3β, β-catenin, and p-FoxO1 induced by IFN-τ, and also blocked the downregulation of TLR4, p-p65, and Bax/Bcl-2 ratio. This suggested that the inhibition of TLR4 signaling by IFN-τ was mediated by the PI3K/AKT pathway. Furthermore, compared with the LPS group, the β-catenin agonist SB216763 led to greater p-FoxO1 and lower p-p65 and cell apoptosis. In contrast, knockdown of β-catenin using small interfering RNA had the opposite effects. To explore the role of FoxO1 on the inhibition of TLR4 by IFN-τ, we employed LY294002 to inhibit the PI3K/AKT while FoxO1 was knocked down. Results revealed that the knockdown of FoxO1 blocked the upregulation of TLR4 and p-p65 induced by LY294002, and enhanced the inhibition of IFN-τ on TLR4, p-p65, and cell apoptosis. Overall, these findings confirmed that IFN-τ can protect endometrial epithelial cells against inflammatory injury via suppressing TLR4 activation through the regulation of the PI3K/AKT/β-catenin/FoxO1 axis. These represent new insights into the molecular mechanisms underlying the anti-inflammatory function of IFN-τ in BEEC, and also provide a theoretical basis for further studies on the in vivo application of IFN-τ to help prevent negative effects of endometritis.
- 1 January 2024
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 107 (1) , 555-572
Interferon-tau protects bovine endometrial epithelial cells against inflammatory injury by regulating the PI3K/AKT/β-catenin/FoxO1 signaling axis
Endometritis is one of the most common causes of infertility in dairy cows, and is histopathologically characterized by inflammation and damage of endometrial epithelium. Interferon-tau (IFN-τ) is a novel type I interferon secreted by ruminant trophoblast cells with low cytotoxicity even at high doses. Previous studies suggested that IFN-τ plays an important role in inflammation. However, the mechanisms whereby IFN-τ may modulate the inflammatory responses in the bovine endometrium are unknown. In the present study, primary bovine endometrial epithelial cells (BEEC) isolated from fresh and healthy uterine horns were used for in vitro studies. The integrity of BEEC was assessed by immunofluorescence staining for cytokeratin 18 (CK-18, a known epithelial marker). For the experiments, BEEC were stimulated with different concentrations of lipopolysaccharide (LPS; 0-20 µg/mL) for different times (0-24 h). Cell viability and apoptosis were assessed via CCK-8 and flow cytometry. In a preliminary study, we observed that compared with the control group without LPS, 10 µg/mL of LPS stimulation for 24 h induced apoptosis. In a subsequent study, 20 or 40 ng/mL of IFN-τ alleviated LPS-induced apoptosis. Relative to the LPS group, western blotting further revealed that IFN-τ inhibited the protein abundance of TLR4 and phosphorylated (p-) p65 (p-p65) and Bax/Bcl-2 ratio, suggesting that IFN-τ can protect BEEC against inflammatory injury. Furthermore, the protein abundance of p-phosphoinositide 3-kinase (p-PI3K), p-protein kinase B (p-AKT), p-glycogen synthase kinase-3β (p-GSK3β), β-catenin, and p-forkhead box O1 (p-FoxO1) was lower in the LPS group, whereas IFN-τ upregulated their abundance. The use of LY294002, a specific inhibitor of PI3K/AKT, attenuated the upregulation of p-PI3K, p-AKT p-GSK3β, β-catenin, and p-FoxO1 induced by IFN-τ, and also blocked the downregulation of TLR4, p-p65, and Bax/Bcl-2 ratio. This suggested that the inhibition of TLR4 signaling by IFN-τ was mediated by the PI3K/AKT pathway. Furthermore, compared with the LPS group, the β-catenin agonist SB216763 led to greater p-FoxO1 and lower p-p65 and cell apoptosis. In contrast, knockdown of β-catenin using small interfering RNA had the opposite effects. To explore the role of FoxO1 on the inhibition of TLR4 by IFN-τ, we employed LY294002 to inhibit the PI3K/AKT while FoxO1 was knocked down. Results revealed that the knockdown of FoxO1 blocked the upregulation of TLR4 and p-p65 induced by LY294002, and enhanced the inhibition of IFN-τ on TLR4, p-p65, and cell apoptosis. Overall, these findings confirmed that IFN-τ can protect endometrial epithelial cells against inflammatory injury via suppressing TLR4 activation through the regulation of the PI3K/AKT/β-catenin/FoxO1 axis. These represent new insights into the molecular mechanisms underlying the anti-inflammatory function of IFN-τ in BEEC, and also provide a theoretical basis for further studies on the in vivo application of IFN-τ to help prevent negative effects of endometritis.